Hemagen Diagnostics Price on May 23, 2023
HMGNDelisted Stock | USD 0.0001 0.00 0.00% |
If you're considering investing in Hemagen Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Hemagen Diagnostics stands at 0.0001, as last reported on the 13th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Hemagen Diagnostics, which you can use to evaluate the volatility of the firm.
Hemagen Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Hemagen |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
HMGN |
Based on monthly moving average Hemagen Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hemagen Diagnostics by adding Hemagen Diagnostics to a well-diversified portfolio.
Hemagen Diagnostics Valuation on May 23, 2023
It is possible to determine the worth of Hemagen Diagnostics on a given historical date. On May 23, 2023 Hemagen was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Hemagen Diagnostics pink sheet. Still, in general, we apply an absolute valuation method to find Hemagen Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Hemagen Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Hemagen Diagnostics' related companies.
Open | High | Low | Close | Volume | |
0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
05/23/2023 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 65,333 |
0.0001 | 0.0001 | 0.0001 | 0.0001 | 100.00 |
Backtest Hemagen Diagnostics | | | Hemagen Diagnostics History | | | Hemagen Diagnostics Valuation | Previous | Next |
Hemagen Diagnostics Trading Date Momentum on May 23, 2023
On May 24 2023 Hemagen Diagnostics was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . The trading volume for the day was 100.0. The trading history from May 24, 2023 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Hemagen Diagnostics Fundamentals Correlations and Trends
By evaluating Hemagen Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Hemagen Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Hemagen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Hemagen Diagnostics Pink Sheet history
Hemagen Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Hemagen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Hemagen Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Hemagen Diagnostics stock prices may prove useful in developing a viable investing in Hemagen Diagnostics
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 15 people.
Hemagen Diagnostics Pink Sheet Technical Analysis
Hemagen Diagnostics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Hemagen Diagnostics Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
Hemagen Diagnostics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Hemagen Diagnostics December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how Hemagen Diagnostics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hemagen Diagnostics shares will generate the highest return on investment. By undertsting and applying Hemagen Diagnostics pink sheet market strength indicators, traders can identify Hemagen Diagnostics entry and exit signals to maximize returns
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Hemagen Pink Sheet
If you are still planning to invest in Hemagen Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hemagen Diagnostics' history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Money Managers Screen money managers from public funds and ETFs managed around the world |